Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$264,709
+$13,489 QoQ
Shares Held
731
+2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,640
of 3,140 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Mar 31, 2026CallValue
$281,480
CallShares
800
PutValue
$281,480
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AlphaGrep UK Ltd holds $2,660,313 across 6 Drug Manufacturers - General names. AMGN ranks #4 (10.0% of the industry book) .
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $264,709 | 731 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $251,220 | 714 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $281,480 | 800 | Call | Sole | 2026-08-13 | |
| 2026-03-31 | $281,480 | 800 | Put | Sole | 2026-08-13 | |
| 2025-12-31 | $379,024 | 1,158 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||